CXCL10 predominantly targets T cells, and its interaction with the CXCR3 receptor on T-cell surfaces promotes its recruitment to tumor sites, thereby augmenting anti-tumor immunity (25, 26). This evidence concerns the gene CXCL10 and neoplasm.